General pharmacology of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways Article

Tordjman, C, Andre, N, Bresson, Y et al. (2003). General pharmacology of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways . 53(12), 844-849.

cited authors

  • Tordjman, C; Andre, N; Bresson, Y; Bellot, I; Deschamps, C; Pastoureau, P; Wierzbicki, M

sustainable development goals

authors

publication date

  • January 1, 2003

keywords

  • 5-LIPOXYGENASE
  • ANTAGONISTS
  • CAS 181308-6-9
  • Chemistry
  • Chemistry, Medicinal
  • Chemistry, Multidisciplinary
  • DAMAGE
  • Life Sciences & Biomedicine
  • MICE
  • NONSTEROIDAL ANTIINFLAMMATORY DRUGS
  • Pharmacology & Pharmacy
  • Physical Sciences
  • RATS
  • S 19812, gastrointestinal tolerance, general pharmacology
  • Science & Technology
  • butanamide derivative
  • cyclooxygenase

publisher

  • GEORG THIEME VERLAG KG

start page

  • 844

end page

  • 849

volume

  • 53

issue

  • 12